PPARG and diabetes mellitus: Focusing on the PPARγ pathway, we identify a mechanism by which UC cells regulate NECTIN4 expression, and we evaluate the effects of PPARγ agonists, which were initially approved for diabetes, on the activity and therapeutic window of NECTIN4-CAR T cells.